Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
An equine health expert has recently suggested lameness needs to be redefined to reflect new assessment techniques.
Kindred Biosciences has said its pipeline of monoclonal antibodies (mAbs) are causing a stir among potential commercial collaborators.
Zoetis has launched the chewable version of its Clavamox antibiotic for dogs and cats in the US.
Ann Arbor, Michigan-based Zomedica has posted a higher net loss in the second quarter of 2017 as it continues to invest in R&D and commercialization strategies.
Australian firm Jurox has entered a sales and a co-marketing agreement that will grow the amount of products it offers the US companion animal market.
The USDA has approved a 15-month duration of immunity (DOI) claim for Zoetis' Vanguard crLyme vaccine.
Aurora Pharmaceutical has received US authorization for a reproductive product in horses.
Kindred Biosciences has reported a higher net loss during the second quarter of 2017 on the back of increased R&D expenses.
Italian feed additive specialist Prosol has launched its established probiotic Biosprint in China.
Anthelmintic resistance in gastro intestinal parasites of sheep, goats, cattle and horses has been highlighted as an unmet need in Australian animal health.
US animal health charity the Morris Animal Foundation (MAH) is funding researchers in Australia to try and help save the country's iconic koala bear from perishing from two different diseases.
The Minnesota Board of Animal Health (MBAH) has placed canine influenza back on its official list of reportable diseases.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.